Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Market Value Added (MVA)

Microsoft Excel

Market value added (MVA) is the difference between a firm fair value and its invested capital. MVA is a measure of the value a company has created in excess of the resources already committed to the enterprise.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

MVA

Medtronic PLC, MVA calculation

US$ in millions

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Fair value of debt1
Operating lease liability
Market value of common equity
Noncontrolling interests
Less: Available-for-sale debt securities
Market (fair) value of Medtronic
Less: Invested capital2
MVA

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 Fair value of debt. See details »

2 Invested capital. See details »


An analysis of the market value added (MVA) from April 2021 to April 2026 reveals a substantial contraction in the premium the market assigns to the organization over its invested capital. While a positive MVA was maintained throughout the period, the magnitude of this value has decreased significantly, indicating a decline in market capitalization relative to the capital employed in the business.

Market Value Trends
A marked decline is observed in the fair market value, which fell from a peak of 190,499 million USD in 2021 to 121,450 million USD by 2026. This trajectory is characterized by a sharp initial drop between 2021 and 2022, followed by a period of volatility, including a temporary recovery in 2025 before declining again in 2026.
Invested Capital Stability
The invested capital remained remarkably consistent over the six-year period, fluctuating within a narrow range between a low of 68,670 million USD in 2024 and a high of 72,405 million USD in 2021. This stability indicates that the changes in MVA were not driven by significant expansions or contractions in the capital base.
Market Value Added (MVA) Dynamics
The MVA experienced a severe compression, plummeting from 118,094 million USD in 2021 to 50,362 million USD in 2026. The most significant erosion of value occurred between 2021 and 2022, where MVA decreased by approximately 44.7%. Because the invested capital remained nearly flat, the reduction in MVA is directly attributable to the compression of the market's valuation of the entity.
Correlation and Insights
There is a direct correlation between the market fair value and the MVA. The brief uptick in MVA observed in 2025 corresponds precisely with the increase in market value, confirming that the MVA is currently driven by external market sentiment rather than internal changes in invested capital. The overall downward trend suggests a diminishing market premium over the book value of the invested capital.


MVA Spread Ratio

Medtronic PLC, MVA spread ratio calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Market value added (MVA)1
Invested capital2
Performance Ratio
MVA spread ratio3
Benchmarks
MVA Spread Ratio, Competitors4
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 MVA. See details »

2 Invested capital. See details »

3 2026 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × ÷ =

4 Click competitor name to see calculations.


The financial performance indicators for Medtronic PLC between April 2021 and April 2026 reveal a significant contraction in market-perceived value creation relative to the capital employed. While the capital base has remained remarkably stable, the market value added has experienced a substantial long-term decline, leading to a compression of the MVA spread ratio.

Market Value Added (MVA)
A pronounced downward trajectory is observed in the MVA, which fell from a peak of US$ 118,094 million in April 2021 to US$ 50,362 million by April 2026. The most significant erosion occurred between 2021 and 2022, where value dropped by approximately 44.7%. Despite a temporary recovery in April 2025 to US$ 61,120 million, the value subsequently declined again, indicating volatility in market valuation and a general trend of diminished excess value.
Invested Capital
Invested capital has exhibited high stability over the six-year period, fluctuating within a narrow range between US$ 68,670 million and US$ 72,405 million. This consistency indicates that the changes observed in the MVA and the spread ratio are driven by external market valuation factors rather than significant changes in the company's internal capital structure or investment levels.
MVA Spread Ratio
The MVA spread ratio exhibits a strong negative correlation with the timeline, declining from 163.10% in April 2021 to 70.84% in April 2026. This decline represents a reduction in the premium the market assigns to the company's invested capital. The ratio remained below 100% from April 2022 onwards, suggesting that the market's valuation of the company's ability to generate value above its cost of capital has weakened considerably compared to the 2021 baseline.

In summary, the data indicates a decoupling between a stable capital investment strategy and a declining market valuation. The persistent drop in the MVA spread ratio underscores a diminishing market confidence in the company's capacity to create significant incremental value over its invested capital base.



MVA Margin

Medtronic PLC, MVA margin calculation, comparison to benchmarks

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Selected Financial Data (US$ in millions)
Market value added (MVA)1
 
Net sales
Add: Increase (decrease) in deferred revenue
Adjusted net sales
Performance Ratio
MVA margin2
Benchmarks
MVA Margin, Competitors3
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 MVA. See details »

2 2026 Calculation
MVA margin = 100 × MVA ÷ Adjusted net sales
= 100 × ÷ =

3 Click competitor name to see calculations.


The financial performance from April 2021 to April 2026 reveals a notable divergence between operational growth and market-based value creation.

Market Value Added (MVA)
A significant overall decline is observed in the MVA, which dropped from 118,094 million US$ in 2021 to 50,362 million US$ by 2026. The most substantial contraction occurred between 2021 and 2022, where the value fell by nearly 45%. Although a temporary recovery to 61,120 million US$ was recorded in 2025, the value returned to a downward trajectory in 2026.
Adjusted Net Sales
Operational expansion is evident through a consistent increase in adjusted net sales. Revenue grew from 30,182 million US$ in 2021 to 36,418 million US$ in 2026. This steady growth indicates a strengthening of the company's top-line performance over the six-year period.
MVA Margin
The MVA margin experienced a sharp contraction, falling from 391.27% in 2021 to 138.29% in 2026. This decline demonstrates that the market valuation of the company's value creation has diminished significantly relative to its sales volume. A brief improvement to 182.29% in 2025 was unable to offset the broader trend of margin erosion, suggesting a decrease in the market's premium assigned to the company's growth.